Company Profiles

driven by the PitchBook Platform

ApoH-Technologies

ApoH-Technologies
2000 FOUNDED
M&A STATUS
1-10 EMPLOYEES
Early Stage VC LATEST DEAL TYPE
$2.38M LATEST DEAL AMOUNT
$2.38M TOTAL AMOUNT RAISED
Description

Provider of biological diagnostic products designed to enhance the detection of infectious agents. The company's biological diagnostic products remove analysis-interfering inhibitors and are non-recombinant protein immobilized on plates or on magnetic beads, enabling doctors to improves diagnostic sensitivity.

Website:
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Laboratory Services (Healthcare)
Primary Office
94, Allée des Fauvettes
34280 La Grande Motte
France

+33 (0)6 50 60 33 17
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore ApoH-Technologies’s full profile, request a free trial.

ApoH-Technologies Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC $2.38M $2.38M Completed Startup
1. Merger/Acquisition 01-Oct-2000 Completed Startup
To view this company’s complete deal history including valuation and funding request access »

ApoH-Technologies Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Biotek Partners Other Minority 000 0000 000000 0
Grenoble Angels Network Other Minority 000 0000 000000 0
Psorimmune Other Minority 000 0000 000000 0
Sopromec Participations PE/Buyout Minority 000 0000 000000 0
Succès Europe Venture Capital Minority 000 0000 000000 0

You’re viewing 5 of 5 investors.

ApoH-Technologies Executive Team (2)

Name Title Board
Seat
Contact
Info
Ilias Stefas Ph.D President, Chief Executive Officer & Co-Founder
Francisco Veas Ph.D Chief Scientific Officer & Co-Founder

You’re viewing 2 of 2 executives.